This inventor holds 1 USPTO granted patent. Top assignee: Renovo Limited. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Mark Ferguson - Innovator in Pharmaceutical Compositions
Introduction
Mark Ferguson is a notable inventor based in Manchester, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance the biological activity of TGF-β superfamily members. His innovative work has implications for wound healing and pain management.
Latest Patents
Mark Ferguson holds 1 patent related to pharmaceutical compositions. This invention provides compositions that include TGF-β superfamily members and sugars, which improve recovery and increase the biological activity of these members. The patent also discusses the use of these compositions in treating wounds and reducing injection pain.
Career Highlights
Ferguson is associated with Renovo Limited, where he has been instrumental in advancing pharmaceutical research. His work focuses on creating effective medicaments that address significant medical challenges.
Collaborations
Throughout his career, Mark has collaborated with notable colleagues such as Hugh Gerard Laverty and Sharon O'Kane. These partnerships have contributed to the success of his innovative projects.
Conclusion
Mark Ferguson's contributions to pharmaceutical compositions demonstrate his commitment to improving medical treatments. His work continues to influence the field and offers promising solutions for various health issues.